罗氏公司在 CE 标记国家推出快速检测,可检测 250 种呼吸道病原体,包括 SARS-CoV-2,流感和 RSV. Roche launches rapid test detecting 250 respiratory pathogens, including SARS-CoV-2, flu, and RSV, in CE-mark countries.

罗氏在接受CE标志的国家推出了cobas eplex呼吸道病原体组3,这是一种快速检测,可检测多达250种呼吸系统病毒和细菌,包括SARS-CoV-2,流感和RSV. Roche has launched the cobas eplex respiratory pathogen panel 3 in CE-mark-accepting countries, a rapid test detecting up to 250 respiratory viruses and bacteria, including SARS-CoV-2, flu, and RSV. 设计用于cobas eplex系统,需要不到一分钟的实践时间并提供快速结果,帮助高风险患者及时治疗. Designed for the cobas eplex system, it requires under a minute of hands-on time and delivers quick results, aiding timely treatment for high-risk patients. 该测试支持向治疗,减少不必要的抗生素使用,并根据当地疾病模式实现可定制面板. The test supports targeted therapy, reduces unnecessary antibiotics, and enables customizable panels based on local disease patterns. 作为罗氏不断努力改善呼吸系统疾病诊断的一部分. It is part of Roche’s ongoing effort to improve diagnostics for respiratory illnesses.